slides · global inventory
Sparkline
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 22,963
Current window 15,211-15,240
Pages 766
Rows per page 30
Arc
15,211-15,240 of 22,963
63
The slide uses a human anatomy diagram to map specific patient counts to disease locations.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
64
The slide uses a hub-and-spoke diagram to illustrate the interaction of LSD1 with various protein complexes, receptors, and RNAs.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
65
The slide uses a biological process diagram to explain the mechanism of action for a drug candidate ('539).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
66
The slide uses a process flow diagram to explain the therapeutic mechanism.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
67
Exscientia | Investor Presentation Deck | 93 slidesExscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
68
The slide uses a three-column layout to define the technical requirements for a drug candidate.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
69
The table uses a traffic-light color coding system to indicate performance against criteria.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
70
The slide outlines a specific workflow involving generative design, ML, and active learning.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
71
The chart uses a scatter plot to visualize the Pareto front in drug discovery, highlighting the selection of compounds 1 and 2.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
72
The slide uses two distinct chart types (dot plot and line chart with error bars) to illustrate the safety profile of the drug candidate '539.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
73
Data shows heterogeneity of response across different patient samples, categorized by differentiation level.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
74
The slide uses a heatmap to visualize synergy (green = yes, light green = no) across 6 drug combinations and 14 patient samples.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
75
Includes statistical significance markers (asterisks) and safety observation regarding body weight.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
76
Uses Bliss Independence Model for synergy calculation. Includes a heatmap of synergy across subtypes and dose-response curves for two specific models (DMS79 and H345).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
01
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Setup1 hit
02
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Setup1 hit
03
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Setup1 hit
04
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · So What Cascade1 hit
05
Includes a dual-axis line chart for historical trends and a table for future projections.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · So What Cascade1 hit
06
The chart compares 2023 quarterly volumes against Q1 2024 volume.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · So What Cascade1 hit
07
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · So What Cascade1 hit
08
The chart shows quarterly container volume (FEU) for 2023 and Q1 2024.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · So What Cascade1 hit
09
The chart shows quarterly container volume comparisons between 2023 and 2024, with a specific note on sailing frequency impact.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · So What Cascade1 hit
10
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · So What Cascade1 hit
11
The chart shows quarterly operating income for 2023 (dark blue) and Q1 2024 (orange).Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · So What Cascade1 hit
12
Includes GAAP EPS and EBITDA reconciliation metrics.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · EvidenceLoop · Pareto Focus1 hit
13
The chart shows a bridge from starting cash flow to net change in cash.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · EvidenceLoop · Pareto Focus1 hit
14
Includes specific footnotes regarding debt calculation and post-period tax refund events.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · EvidenceLoop · Pareto Focus1 hit
15
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · 2024 OutlookLoop · Cost Of Inaction1 hit
16
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Valuation Table1 hit